Evidence map›Paper›PMID 7576303›Full record

ReviewMolecular neurobiology

VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment.

J M Muller, V Lelievre, L Becq-Giraudon, A C Meunier

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 55 citations in OpenAlex.

  1. Niosomes: a novel targeted drug delivery system for cancer.Medical oncology (Northwood, London, England) · 2022
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Antagonism of VIP-stimulated cyclic AMP formation in chick brain.Journal of molecular neuroscience : MN · 2003
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J M MullerLaboratoire de Biologie des Interactions Cellulaires, CNRS URA 1869, Poitiers, France.
V Lelievre
L Becq-Giraudon
A C Meunier
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In addition to its commonly recognized status as a neuromodulator of virtually all vital functions, including neurobiological, the neuropeptide VIP plays a role in the control of cell growth and differentiation and of neuronal survival. Through these actions, VIP, whose impact appears early in ontogeny, may possess developmental functions. VIP can be stimulatory or inhibitory on cell growth in function of the model considered. The growth regulatory actions of VIP, which are often independent of cAMP, are most likely significant when mitogenic or trophic factors, eventually released by nontarget cells, are simultaneously present in the extracellular medium. The intracellular mechanisms that mediate these actions of VIP may involve different transduction cascades triggered by subsets of VIP binding sites that may coexist in the same tissue.

Indexed as

AnimalsCell DifferentiationCell DivisionCyclic AMPGene Expression Regulation, DevelopmentalHumansHypothalamusInterneuronsNeoplasmsNervous SystemNeuronsRabbitsRatsReceptors, Vasoactive Intestinal PeptideSignal TransductionVasoactive Intestinal PeptideCyclic AMPReceptors, Vasoactive Intestinal PeptideVasoactive Intestinal Peptide

Identifiers

PMID7576303
OpenAlexW2006754667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.